HIGHLIGHTS
- who: Hypertrophic cardiomyopathy MYBPC et al. from the Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands have published the Article: BIO FOr CARE: biomarkers of hypertrophic cardiomyopathy development and progression in carriers of Dutch founder truncating MYBPC3 variants—design and status, in the Journal: (JOURNAL)
- what: In the BIO FOr CARe (Identification of BIOmarkers of hypertrophic cardiomyopathy development and progression in Dutch MYBPC3 FOunder variant CARriers) study the authors aim to investigate predictive factors and effect modifiers for penetrance and progression of HCM in the genetically homogeneous group of Dutch carriers of truncating MYBPC3 variants . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.